Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease

por Thomas, Katja, Schrötter, Hagen, Halank, Michael, Ziemssen, Tjalf
Publicado 2014

Practical management of riociguat in patients with pulmonary arterial hypertension

por Halank, Michael, Tausche, Kristin, Grünig, Ekkehard, Ewert, Ralf, Preston, Ioana R.
Publicado 2019

Anxiety, Depression and Quality of Life in Pulmonary Hypertension: A Comparison of Incident and Prevalent Cases

por Pfeuffer-Jovic, Elena, Joa, Franziska, Halank, Michael, Krannich, Jens-Holger, Held, Matthias
Publicado 2022

Riociguat dose titration in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH)

por Ghofrani, Hossein A, Hoeper, Marius M, Hoeffken, Gert, Halank, Michael, Weimann, Gerrit, Grimminger, Friedrich
Publicado 2009

Haemoptysis due to pulmonary venous stenosis

por Braun, Silke, Platzek, Ivan, Zöphel, Klaus, Weise, Matthias, Kolditz, Martin, Halank, Michael, Hoeffken, Gert
Publicado 2014

Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1/-2 studies

por Cartin-Ceba, Rodrigo, Halank, Michael, Ghofrani, Hossein-Ardeschir, Humbert, Marc, Mattson, John, Fritsch, Arno, Krowka, Michael
Publicado 2018

Efficacy and safety of nasal high-flow oxygen in COPD patients

por Vogelsinger, Helene, Halank, Michael, Braun, Silke, Wilkens, Heinrike, Geiser, Thomas, Ott, Sebastian, Stucki, Armin, Kaehler, Christian M.
Publicado 2017

Mutually reinforcing effects of genetic variants and interferon-β 1a therapy for pulmonary arterial hypertension development in multiple sclerosis patients

por Lerche, Marianne, Eichstaedt, Christina A., Hinderhofer, Katrin, Grünig, Ekkehard, Tausche, Kristin, Ziemssen, Tjalf, Halank, Michael, Wirtz, Hubert, Seyfarth, Hans-Jürgen
Publicado 2019

Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH

por Gall, Henning, Vachiéry, Jean-Luc, Tanabe, Nobuhiro, Halank, Michael, Orozco-Levi, Mauricio, Mielniczuk, Lisa, Chang, MiKyung, Vogtländer, Kai, Grünig, Ekkehard
Publicado 2018

Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis

por Ewert, Ralf, Ittermann, Till, Habedank, Dirk, Held, Matthias, Lange, Tobias J., Halank, Michael, Winkler, Jörg, Gläser, Sven, Olschewski, Horst, Kovacs, Gabor
Publicado 2019

Monotherapy in patients with pulmonary arterial hypertension at four German PH centres

por Stubbe, Beate, Seyfarth, Hans-Jürgen, Kleymann, Janina, Halank, Michael, Al Ghorani, Hussam, Obst, Anne, Desole, Susanna, Ewert, Ralf, Opitz, Christian F.
Publicado 2021

Fibrinogen plasma concentration is an independent marker of haemodynamic impairment in chronic thromboembolic pulmonary hypertension

por Hennigs, Jan K., Baumann, Hans Jörg, Lüneburg, Nicole, Quast, Gesine, Harbaum, Lars, Heyckendorf, Jan, Sydow, Karsten, Schulte-Hubbert, Bernhard, Halank, Michael, Klose, Hans
Publicado 2014

Exercise Training Improves Exercise Capacity and Quality of Life in Patients with Inoperable or Residual Chronic Thromboembolic Pulmonary Hypertension

por Nagel, Christian, Prange, Felix, Guth, Stefan, Herb, Jochen, Ehlken, Nicola, Fischer, Christine, Reichenberger, Frank, Rosenkranz, Stephan, Seyfarth, Hans-Juergen, Mayer, Eckhard, Halank, Michael, Grünig, Ekkehard
Publicado 2012

Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis – The Predictive Value of Exercise Capacity and Gas Exchange Efficiency

por Gläser, Sven, Obst, Anne, Koch, Beate, Henkel, Beate, Grieger, Anita, Felix, Stephan B., Halank, Michael, Bruch, Leonhard, Bollmann, Tom, Warnke, Christian, Schäper, Christoph, Ewert, Ralf
Publicado 2013

Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy

por Knudsen, Lars, Schurawlew, Alexander, Nickel, Nils, Tiede, Henning, Ghofrani, Hossein A, Wilkens, Heinrike, Ewert, Ralf, Halank, Michael, Klose, Hans, Bäzner, Carlos, Behr, Jürgen, Hoeper, Marius M
Publicado 2011

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil

por Jansa, Pavel, Kopeć, Grzegorz, Torbicki, Adam, Sadushi‐Kolici, Roela, Campean, Ioana‐Alexandra, Halank, Michael, Simkova, Iveta, Steringer‐Mascherbauer, Regina, Salobir, Barbara, Klepetko, Walter, Lindner, Jaroslav, Lang, Irene M.
Publicado 2023

Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

por Harzheim, Dominik, Klose, Hans, Pinado, Fabiola Peña, Ehlken, Nicola, Nagel, Christian, Fischer, Christine, Ghofrani, Ardeschir, Rosenkranz, Stephan, Seyfarth, Hans-Jürgen, Halank, Michael, Mayer, Eckhard, Grünig, Ekkehard, Guth, Stefan
Publicado 2013

Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction: Study protocol for a randomized c...

por Mascherbauer, Julia, Grünig, Ekkehard, Halank, Michael, Hohenforst-Schmidt, Wolfgang, Kammerlander, Andreas A., Pretsch, Ingrid, Steringer-Mascherbauer, Regina, Ulrich, Silvia, Lang, Irene M., Wargenau, Manfred, Frey, Reiner, Bonderman, Diana
Publicado 2016

Trends in COVID-19-associated mortality in patients with pulmonary hypertension: a COMPERA analysis

por Schmidt, Kai-Helge, Milger, Katrin, Pausch, Christine, Huscher, Doerte, Pittrow, David, Grünig, Ekkehard, Staehler, Gerd, Gall, Henning, Distler, Oliver, Skowasch, Dirk, Halank, Michael, Wilkens, Heinrike, Held, Matthias, Klose, Hans, Hoeper, Marius M.
Publicado 2023

Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?

por Theobald, Vivienne, Benjamin, Nicola, Seyfarth, Hans-Jürgen, Halank, Michael, Schneider, Marc A., Richtmann, Sarah, Hinderhofer, Katrin, Xanthouli, Panagiota, Egenlauf, Benjamin, Seeger, Rebekka, Hoeper, Marius M., Jonigk, Danny, Grünig, Ekkehard, Eichstaedt, Christina A.
Publicado 2022